Skip to main content
Publications
AlHarbi O, Farsakh NA, Al-Awadhi A, Al-Taweel T, Mikhail I, Batwa F, Bedran K, Balkan D, Cappelleri JC, Boeri M, Habjoka S, Mosli M. Patient preferences for ulcerative colitis treatment in the middle east region: results from a discrete-choice experiment. Poster presented at the 2022 Digestive Disease Week; May 21, 2022. San Diego, CA.
Vass CM, Boeri M, Karim S, Marshall D, Craig B, Ho KA, Mott D, Ngorsuraches S, Badawy SM, Mühlbacher A, Gonzalez JM, Heidenreich S. Accounting for preference heterogeneity in discrete-choice experiments: an ISPOR Special Interest Group Report. Value Health. 2022 May;25(5):685-94.
Walsh DA, Boeri M, Abraham L, Atkinson J, Bushmakin AG, Cappelleri JC, Hauber B, Klein K, Russo L, Viktrup L, Turk D. Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: a latent class analysis. Eur J Pain. 2022 Mar;26(3):648-67. doi: 10.1002/ejp.1892
Jones L, Boeri M, Christie M, Durance I, Evans KL, Fletcher D, Harrison L, Jorgensen A, Masante D, McKinlay J, Paterson DM, Schmucki R, Short C, Small N, Southon G, Stojanovic T, Waters R. Can we model cultural ecosystem services, and are we measuring the right things? People and nature. 2022 Feb;4(1):166-79. doi: 10.1002/pan3.10271
Turk DC, Boeri M, Abraham L, Atkinson J, Bushmakin A, Cappelleri JC, Hauber B, Klein K, Russo L, Viktrup L, Walsh DA. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment. Osteoarthritis Cartilage. 2020 Sep 1;28(9):1202-13. doi: 10.1016/j.joca.2020.06.006
Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker L-G, Montgomery ET. Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020 Jun 16;23:e25528. doi: 10.1002/jia2.25528
Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A. Efficacy is not everything: eliciting women's preferences for a vaginal HIV prevention product using a discrete-choice experiment. AIDS Behav. 2020 May;24(5):1443-51. doi: 10.1007/s10461-019-02715-1
Boeri M, Abraham L, Hauber B, Atkinson J, Bushmakin AG, Cappelleri JC, Russo L, Viktrup L, Klein K, Walsh D, Turk D. Exploring heterogeneity in preferences for attributes of pharmaceutical treatments for osteoarthritis and chronic low back pain in the United States: a latent class approach. Presented at the 2020 ISPOR Virtual Conference; May 18, 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S325. Previously presented at the ISPOR 2019 European Conference. doi: 10.1016/j.jval.2020.04.371
Boeri M, Abraham L, Hauber B, Atkinson J, Bushmakin AG, Cappelleri JC, Russo L, Viktrup L, Walsh D, Turk D. Exploring heterogeneity in preferences for attributes of pharmaceutical treatments for osteoarthritis and chronic low back pain in the United Kingdom; a latent class approach. Presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Nov 1; 22(Supplement 3):S923. doi: 10.1016/j.jval.2019.09.2738
Augustin M, Feldman S, Poulos C, Gilloteau I, Mange B, Boeri M, Boehm K, Melzer N, Gutknecht M. Patient preferences for treatment of moderate to severe psoriasis: a discrete choice experiment study in Germany. Poster presented at the 28th European Academy of Dermatology and Venereology (EADV) Congress; October 11, 2019. Madrid, Spain.
Turk D, Boeri M, Abraham L, Hauber B, Atkinson J, Bushmakin AG, Cappelleri JC, Russo L, Viktrup L, Walsh DA. Patient preferences for attributes of treatments for chronic pain associated with osteoarthritis pain and chronic low back pain that differentiate nerve-growth factor inhibitors, nonsteroidal anti-inflammatory drugs, and opioids in the US: a Discrete-Choice Experiment (DCE). Presented at the 2019 ACR/ARP Annual Meeting; November 12, 2019. Atlanta, GA. [abstract] Arthritis Rheumatol. 2019 Oct; 71(suppl 10). doi: 10.1002/art.v71.s10